 |
BRAZIL: A Bold Player Blooms, from Focus Reports, Limited and
Pharmaceutical Executive and Pharmaceutical Global Digest |
 |
Brazil was the last country to enter the financial crisis, and the first to exit. The country is emerging from a decade which saw 40 million of its 200 million inhabitants joining the middle class, and creating a new block of "pharmerging" consumers. This bulging middle class has been the main driver in Brazil's retail pharmaceutical market, more than doubling to US$26 billion and projected to reach top 5 by 2015.
Written after exclusive interviews with Brazil's decision makers from local and multinational companies, manufacturers, distributors, experts, legislators, this is a unique resource for those looking beyond figures.
Contributors include: ANVISA, SINDUSPHARMA, Sanofi, Pfizer, Roche, Novartis, Boehringer Ingelheim, Eli Lilly, Ferring Astellas, Ipsen, and many more.
PDF Report
$129.99
|
|
Focus Reports serves business professionals in the Pharmaceutical industry. The country reports offer a snapshot of the challenges and issues faced by an
industry through the voice and insight of the decision makers at governmental, legislative and corporate levels. They are based on exclusive interviews
conducted by our staff. |
 |
| |
|